NCT06165224View on ClinicalTrials.gov

A Bidirectional Cohort Study of COMMD10 Expression in Tumor Tissues for Predicting Radiosensitivity

RecruitingOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

December 30, 2024

Study Completion Date

June 30, 2025

Conditions

BiomarkerRadiosensitivity

Trial Locations (1)

510515

RECRUITING

Nanfang hospital, Southern medical university, Guangzhou

All Listed Sponsors

lead

Nanfang Hospital, Southern Medical University

OTHER